New device for leg clots tested in first human survey

NCT ID NCT07335341

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study surveys doctors who use the Liberant system to remove fresh blood clots from leg arteries and veins. About 50 patients aged 22 or older will be treated within 72 hours of their procedure. The goal is to confirm the device is safe and works as intended.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome Arterial Occlusive Diseases disease limb ischemia peripheral arterial disease peripheral vascular disease thrombotic disease vascular disorder venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • MedStar Health

    RECRUITING

    Washington D.C., District of Columbia, 003329, United States

    Contact

  • Naples Comprehensive Health

    RECRUITING

    Naples, Florida, 34108, United States

    Contact